Work has been completed on two treatment area improvements, both funded by charity Rosemere Cancer Foundation, which will benefit patients attending Rosemere Cancer Centre, Lancashire and South ...

Back home, however, the stomach cramps worsened and I was alarmed to see blood in my stools, so I made an appointment to see ...

For those with ALK+ NSCLC who received first-line, next-generation ALK TKI monotherapy, continuing ALK TKI with chemotherapy is linked to better outcomes.

Azacitidine-venetoclax showed superior event-free survival and overall response rates compared to traditional induction ...

In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined regimen ...

Investigators sought compare the efficacy and safety of a chemo-free approach to TKI + chemotherapy in newly-diagnosed adult Ph+ ALL.

A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with ...

A chemotherapy-free combination treatment outperformed a combination of targeted therapy and chemotherapy among patients with Ph+ acute lymphoblastic leukemia (ALL) in a new study. The Phase III trial ...

In the Phase III GIMEMA ALL2820 trial, presented at ASH, 94 percent of patients who received the chemo-free regimen had a ...